Moreover, these chemokines were detected in a higher proportion of the IBS patients (98% for ID-IBS; 96% for PI-IBS) compared to the healthy volunteers (53%), suggesting that MCP-1 and MIP-1β may play a significant role in the immunopathogenesis of IBS. Here, CCL4 is linked to irritable bowel syndrome.